JPMorgan Chase
JPM
$351.58
+0.01%
JPMorgan Chase & Co. is a leading global financial services firm providing a comprehensive range of investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. As the largest bank in the United States by assets, it holds a dominant market position with a $4.9 trillion balance sheet, top-tier investment banking fees (8.4% market share), and over 5,000 branches. The current investor narrative centers on the bank's robust earnings growth, driven by strong net interest income and investment banking performance, alongside concerns about the potential impact of a strict Fed inflation target on rate-sensitive sectors and the eventual CEO succession after Jamie Dimon's two-decade tenure.…
JPM
JPMorgan Chase
$351.58
Related headlines
Investment Opinion: Should I buy JPM Today?
We rate JPM as a Buy, given its strong earnings growth, solid profitability, and reasonable valuation. The consensus rating is Buy with an average target of $374.57, implying ~6.5% upside, which we believe is conservative given the momentum.
Sign up to view all
JPM 12-Month Price Forecast
JPM's fundamentals are strong, with accelerating revenue and solid profitability, but the valuation is not cheap. The AI model sees a balanced risk-reward, with a slight bullish tilt due to earnings momentum. If the Fed cuts rates and the economy avoids a recession, JPM could outperform. However, if credit conditions deteriorate, the stock could underperform. We would upgrade to high confidence if revenue growth sustains above 15% and credit costs remain below 2% of loans.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on JPMorgan Chase's 12-month outlook, with a consensus price target around $374.57 and implied upside of +6.5% versus the current price.
Average Target
$374.57
0 analysts
Implied Upside
+6.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$305 - $420
Analyst target range
The target price range spans from a low of $305.00 to a high of $420.00, reflecting a wide spread of 37.7% from low to high. The high target of $420 assumes continued strong earnings growth and multiple expansion, driven by robust capital markets activity and effective cost management. The low target of $305 suggests potential downside from a recession or credit deterioration, which could compress earnings. Recent ratings actions have been predominantly positive, with firms like RBC Capital, Wells Fargo, and Barclays reaffirming Overweight/Outperform ratings in July 2026, while B of A Securities and UBS maintain Buy ratings. This pattern indicates that analysts are confident in JPMorgan's near-term prospects, though the wide target range highlights uncertainty around macroeconomic factors and the eventual CEO transition.
Bulls vs Bears: JPM Investment Factors
JPMorgan presents a compelling bull case with robust revenue growth, strong profitability, and a leading market position, supported by a reasonable valuation and analyst optimism. However, the bear case highlights valuation premium, CEO succession risk, and macro sensitivity that could cap upside. Currently, the bull evidence is stronger given the accelerating earnings momentum and solid fundamentals, but the key tension is whether the market has already priced in perfection. If the Fed's strict inflation stance triggers a recession, credit costs could spike, undermining the earnings growth narrative and compressing the multiple.
Bullish
- Strong Revenue Growth: Q2 2026 revenue surged 17.9% YoY to $82.46B, with sequential growth from $73.66B in Q1, driven by robust net interest income and investment banking fees. This acceleration underscores broad-based strength across consumer and wholesale segments.
- Solid Profitability: Net margin stands at 20.4%, with operating margin at 26.0% and ROE at 15.7%, reflecting efficient cost management and strong credit performance. Q2 net income of $21.2B was up 41% YoY, showcasing earnings power.
- Attractive Valuation: Trailing PE of 16.0x and forward PE of 14.1x are reasonable for a bank of JPM's quality, especially with expected EPS growth of ~9% next year. The PEG ratio of 10.6 is elevated but reflects cyclical earnings, not structural overvaluation.
- Analyst Optimism: Consensus rating is Buy with an average target of $374.57, implying ~6.5% upside from the current price. Recent upgrades from RBC, Wells Fargo, and Barclays reinforce positive sentiment.
Bearish
- High Valuation vs. Peers: At 2.48x price-to-book, JPM trades at a premium to many large-cap banks (typically 1.0-1.5x), leaving limited room for multiple expansion. If earnings normalize, the stock could de-rate.
- CEO Succession Risk: Jamie Dimon has led for two decades; his eventual departure introduces leadership uncertainty. While succession planning is proactive, any misstep could trigger volatility and strategic drift.
- Macro Sensitivity: Beta of 0.98 and a 1-year relative strength of only 0.14% vs. S&P 500 indicate the stock is not immune to market swings. A strict Fed 2% inflation target could keep rates higher, pressuring loan growth and credit quality.
- Elevated Debt Levels: Debt-to-equity of 2.6x is high for a bank, reflecting its leverage model. In a downturn, credit losses could escalate, as seen in past cycles, impacting earnings.
JPM Technical Analysis
JPMorgan's stock is in a strong uptrend, with a 1-year price change of +20.6% and currently trading at $351.58, which is 96% of its 52-week range (low $279.1, high $366.5). This positioning near the highs indicates robust momentum and investor confidence, though it also suggests the stock may be overextended in the short term. The 52-week low of $279.1 provides a clear support level, while the high of $366.5 acts as immediate resistance.
Beta
0.98
0.98x market volatility
Max Drawdown
-15.5%
Largest decline past year
52-Week Range
$279-$367
Price range past year
Annual Return
+20.6%
Cumulative gain past year
| Period | JPM Return | S&P 500 |
|---|---|---|
| 1m | +1.0% | +3.6% |
| 3m | +14.8% | +2.7% |
| 6m | +13.1% | +11.4% |
| 1y | +20.6% | +18.7% |
| ytd | +8.0% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JPM Fundamental Analysis
JPMorgan's revenue trajectory is robust, with Q2 2026 revenue of $82.46 billion, up 17.9% year-over-year, and a sequential increase from $73.66 billion in Q1 2026. The multi-quarter trend shows accelerating growth, with revenue rising from $69.91 billion in Q2 2025 to $82.46 billion in Q2 2026, driven by strong performance across all segments, particularly Commercial and Investment Bank ($19.375 billion) and Consumer & Community Banking ($19.396 billion). This growth is supported by higher net interest income and robust investment banking fees, indicating a healthy demand for credit and capital markets activity.
Quarterly Revenue
$82.5B
2026-06
Revenue YoY Growth
+17.9%
YoY Comparison
Gross Margin
66.5%
Latest Quarter
Free Cash Flow
$140.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JPM Overvalued?
Given JPMorgan's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 16.04x, while the forward PE is 14.06x, indicating that the market expects earnings growth of approximately 14% over the next year. This is supported by the estimated EPS growth from $27.20 (current year) to $29.69 (next year), reflecting a favorable outlook for the bank's profitability.
PE
16.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks stem from JPM's high leverage (debt-to-equity of 2.6x) and reliance on net interest income, which is sensitive to rate changes. The bank's net margin of 20.4% is strong, but a sharp rise in credit losses during an economic downturn could erode earnings, as seen in 2020. Additionally, the payout ratio of 29% and dividend yield of 1.85% are sustainable, but a capital shortfall would force cuts. Revenue concentration in capital markets (8.4% IB share) adds cyclicality, as fees can drop sharply in a slowdown.